Completed PHASE2 INTERVENTIONAL NCT00002655

Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases

Cryosurgical Destruction of Surgically Incurable Liver Tumors

Sponsor: National Cancer Institute (NCI)

Conditions Liver Cancer Metastatic Cancer

Interventions cryosurgery

Updated 5 times since 2017 Last updated: Jul 19, 2013 Started: Mar 31, 1995 Primary completion: Sep 30, 1999 Completion: Sep 30, 1999

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Liver Cancer and Metastatic Cancer and is currently completed. National Cancer Institute (NCI) leads this study, which shows 5 recorded versions since 1995 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 1995

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
University of Colorado, Denver

Data source: University of Colorado, Denver

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Denver, United States